Clinical Trial Update: Efficacy Study of 4CMenB (Bexsero®) to Prevent Gonorrhoea Infection in Gay and Bisexual Men [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating whether the Bexsero meningococcal B vaccine (4CMenB) can prevent gonorrhea infection; the study is currently ACTIVE_NOT_RECRUITING…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gonorrhea

Drugs mentioned

• Bexsero (Meningococcal group B vaccine (4CMenB))

Snippet

Sponsor: Kirby Institute | Conditions: Neisseria Gonorrheae Infection | Phase 3 | Status: ACTIVE_NOT_RECRUITING